Dynavax Technologies Corp

NASDAQ:DVAXUnited States

Nov 11, 2024

Show headlines and story abstract

• Dynavax Technologies to Repurchase $100 Million From Goldman Sachs, from 8:43AM ET on Monday Nov 11, 2024 by MT Newswires

  8:43AM ET on Monday Nov 11, 2024 by MT Newswires
  Companies Mentioned: GS, DVAX
  08:43 AM EST, 11/11/2024 (MT Newswires) -- Dynavax Technologies (DVAX) said Monday it signed a deal with Goldman Sachs (GS) to repurchase $100 million of shares under an accelerated share repurchase transaction, or ASR. The transaction is part of Dy...

• DJ Dynavax Technologies Sets $100 Million Accelerated Stock Buyback, from 8:35AM ET on Monday Nov 11, 2024 by Dow Jones

  8:35AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: DVAX
  
  By Colin Kellaher
  
  Dynavax Technologies said it inked a $280 million accelerated share-repurchase agreement with Goldman Sachs.
  
  The biopharmaceutical Dynavax on Monday said it expects an initial delivery of about 6.1 million shares, representing roughly 80% of the deal, with final settlement in the first quarter.
  

• Dynavax Announces $100 Million Accelerated Share Repurchase Program, from 8:01AM ET on Monday Nov 11, 2024 by PR Newswire

  8:01AM ET on Monday Nov 11, 2024 by PR Newswire
  Companies Mentioned: DVAX

  Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing andcommercializing innovative vaccines, today announced that it has entered into an Accelerated Share Repurchase transaction ("ASR") under an agreement with Goldman Sachs & Co. LLCto repurchase $100 million of the Company's common stock. Dynavax executed the ASR as part of the $200 million share repurchase program authorized by its Board of Directors in November 2024. Upon completion of this ASR, Dynavax will have $100 million remaining under the program.

• Dynavax Announces $100 Million Accelerated Share Repurchase Program, from 8:00AM ET on Monday Nov 11, 2024 by Dow Jones

  8:00AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: DVAX
  
  Dynavax Announces $100 Million Accelerated Share Repurchase Program
  
  PR Newswire
  
  EMERYVILLE, Calif., Nov. 11, 2024
  
  EMERYVILLE, Calif., Nov. 11, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that it has entered into an Accelerated Share Repurchase transaction ("ASR") under an agreement with Goldman Sachs & Co. LLC to repurchase $100 million of the Company's common stock. Dynavax executed the ASR as part of the $200 million share repurchase program authorized by its Board of Directors in November 2024. Upon completion of this ASR, Dynavax will have $100 million remaining under the program.